secwatch.observer — SEC 8-K summary
======================================

Issuer:     ACURA PHARMACEUTICALS, INC (—)
CIK:        0000786947
Form:       8-K
Filed at:   2024-02-14T23:59:59+00:00
Accession:  0001104659-24-023174
Event type: debt
Sentiment:  negative
Materiality: 0.80
Item codes: 1.01, 2.01, 2.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Acura Pharma gets $250K loan from related party AD Pharma; total debt $5.17M due March 31, 2024
--------------------------------------------------------------------------------

- Received $250,000 loan from AD Pharma (65% owner), increasing total debt to $5,169,279 at 5.25% interest, due March 31, 2024.
- Proceeds fund operations only through mid-March; company warns it may need additional financing by March-end to avoid scaling back or bankruptcy.
- AD Pharma (controlled by Mr. Schutte) directly owns ~65% of Acura's common stock; Mr. Schutte personally owns ~13%.
- If no additional financing by end of March, company may need to terminate operations or seek bankruptcy protection, risking total loss of shareholder value.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/786947/000110465924023174/0001104659-24-023174-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/786947/000110465924023174/tm246140d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-023174

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer